We are almost there ...
How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
11 February, 2025•10 min
0
11 February, 2025•10 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
Mubadala acquires a stake in Nord Anglia Education for $600 million
The investment company joins a consortium that plans to expand the UK-based private school operator’s footprint across the Middle East.
You may also like
Business
Reliance’s Vantara is noble but also very clever
Both from the perspective of a common man, who has nothing to do with it, and a Reliance Industries shareholder, who actually funds it, how should one view Anant Ambani’s animal welfare initiative?
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Internet
India declines to participate in PISA in 2025, yet again
For a country aspiring to be a superpower, with more than 250 million children in schools, India’s reluctance to participate in an international student assessment study is confounding.